11:09Coronavirus Outbreak (COVID - 19): WHO Update (28 September 2020)
From the creator
WHO Director-General Dr Tedros Ghebreyesus said interim result from trials on Remdesivir and Interferon have shown that the two drugs “have little or no effect in preventing death from COVID-19 or reducing time in hospital” for COVID-19 patients. Speaking to reporters in Geneva today (16 Oct), Dr Tedros said WHO had launched the Solidarity Trial to evaluate the effectiveness of four drugs for the treatment of COVID-19 some six months ago, and announced discontinued studies on hydroxychloroquine and the combination of Lopinavir and Ritonavir in June and July respectively. He said Solidarity Trial is “the world’s largest randomized controlled trial of COVID-19 therapeutics, involving almost 13,000 patients in 500 hospitals in 30 countries.” He expected the full results to be published “shortly in a leading scientific journal." WHO chief scientist Dr Soumya Swaminathan said, “We have a large body of evidence from randomized clinical trials, very unusual in a pandemic situation to have this body of evidence on drugs within six months. Now that there is a good body of evidence, the guidelines need to be evidence based. And so, countries regulatory agencies are going to be relooking at the data and making decisions. WHO's going to do that but I'm sure that many countries and many regulatory agencies are going to do that as well, because you need to look at the benefits versus the risks, and the cost of course, and the equity considerations. And then, every country will need to ma
Published 2020-10-16 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





